ALT trade ideas
A little update on ALT, Still LongSince last i posted about this stock, it has gone up over $5, and I still believe it has further potential to go even higher.
ALT a top gainer, rising +922.8%. Expect Uptrend continuationAltimmune (ALT, $31.4) was one of top quarterly gainers, jumping +922.8% to $31.4 per share. Tickeron A.I.dvisor analyzed 138 stocks in the Miscellaneous Commercial Services Industry over the last three months, and discovered that 120 of them (86.96%) charted an Uptrend while 18 of them (13.04%) trended down. Tickeron A.I.dvisor found 63 similar cases when ALT's price jumped over 15% within three months. In 38 out of those 63 cases, ALT's price went up during the following month. Based on these historical data, Tickeron A.I. thinks the odds of an Uptrend continuation for ALT are 60%.
ALT's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line
This is a Bullish indicator signaling ALT's price could rise. Traders may explore going long on the ticker or buying call options. Tickeron AI shows that in 24 of 28 cases where ALT's MACD histogram became positive, the price rose further within the following month. The odds of a continued Uptrend are 86%.
Current price $29.03 is above $4.49 the highest resistance line found by Tickeron A.I. Throughout the month of 06/17/20 - 07/20/20, the price experienced a +330% Uptrend. During the week of 07/13/20 - 07/20/20, the stock enjoyed a +8% Uptrend growth.
Bullish Trend Analysis
The Momentum Indicator exceeded the 0 level on June 22, 2020. Traders may consider buying the ticker or exploring call options. Tickeron AI shows that in 43 of 51 cases where the ticker's Momentum Indicator exceeded 0, its price rose further within the subsequent month. The odds of a continued Uptrend are 84%
ALT observationswon't be in on this trade, but if i was this would be what it would look like.
not financial advice.
stay safe.
ALT Altimune studyGood to look at how things played out. I was in this for some of the action. Wondering if we can see the 4.236 or we may be done.
think this has potential to go up againbut i do expect it to pull back to 23-22 dollar range and then go up.
Please like and follow for more.
$ALT Altimmune, Inc. on Breakout WatchAltimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.
ANALYST RATINGS
SELL
UNDER
HOLD
OVER
BUY
NUMBER OF RATINGS 1FULL RATINGS
$ALTTo make it clear! Here you can see the two important variables! The price( red line ) and the Super Trend! No sweat!
Take the Profits w/ ALT and ShortFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. The bull run went too high in my opinion and the current wedge looks like it can receive some steep resistance. I think right now it is at a good level where it is a better idea to not try getting too greedy because just as it went up really high, it can also come crashing down steeply as well. Anyways, proceed with caution. If you like this, it is probably less risky to sell and than rebuy at the dip rather than hold long at this current level.
$ALT Altimmune Inc Upside Targets
Possible trade setup for next impulse move higher.
Alert set for move above $11.70 , and a pick up in volume.
Upside targets as per Fibonacci extensions.
Indicators are Bullish and room to run higher
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
Completes First Development Milestone Toward A Single-DoseFeb. 28, 2020 announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology to protect against COVID-19, the disease caused by the SARS-CoV-2 virus. Altimmune has completed the design and synthesis of the vaccine and is now advancing it toward animal testing and manufacturing.
the COVID-19 vaccine is designed to provide systemic immunity following a single intranasal dose.
A recent Phase 2 clinical study with NasoVAX highlighted the ability of intranasal vaccine delivery to stimulate a durable and broad immune response against the influenza virus.
ir.altimmune.com
$ALT looking for a move to 8 before a pullback then possibly 12 beyond that, looking like a strong trend so far
Altimmune Break out with a 32% upsite potencialA close above 3.25 should allow a quick rise to the resistance of 4.50
Altimmune, Inc. Jumps On Vaccine NewsAltimmune, Inc. is a clinical stage immunotherapeutic biotechnology company, which is focused on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. Its portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. The company was founded in 1997 and is headquartered in Gaithersburg, MD.
ANALYST RATINGS
SELL
UNDER
HOLD
OVER
BUY
NUMBER OF RATINGS 1FULL RATINGS
Is this a valid channel?I would try to search for an entry in this area keeping in mind those fakeouts (stop hunts) before the previous bounces.
1/4/19 ALT @ 3.21 EARNINGSBroke day resistance after 2:30pm, however earnings are pending would not hold overnight but will be watching earnings annoucement and hopefully a afternoon breakout tomoorw
